98217245 - VECTURA

Information

• Trademark
• 98217245

• Source

• Serial Number

  98217245

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 40 - Treatment of materials
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  October 10, 2023
  a year ago

• Transaction Date

  September 16, 2024
  2 months ago

• Status Date

  September 12, 2024
  2 months ago

• Location Date

  September 11, 2024
  2 months ago

• Status Code

  692

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  PERRY, KIMBERLY

• Attorney Docket Number

  AJO2-429-TM

  Attorney Name

  Molly B. Markley

  Law Office Assigned Location Code

  M30

• Owners

  • Vectura GmbH

Case File Statements

• GS0401: Custom manufacture of pharmaceuticals; Consulting services in the field of pharmaceutical formulation, development of medical applications for drugs and pharmaceutical formulations, drug design, drug formulation, pharmaceutical formulation, and development of pharmaceutical formulations
• GS0051: Pharmaceutical and veterinary preparations for the treatment of diseases or conditions of the respiratory system; pharmaceutical and veterinary preparations for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynaecological conditions; pharmaceutical and veterinary preparations for the alleviation or prevention of pain or inflammation; inhalers filled with powders for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynaecological conditions; pharmaceutical preparations, namely, powders for asthma inhalers; pharmaceutical preparations, namely, powders for transdermal injection for the alleviation or prevention of pain, for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; pharmaceutical and veterinary preparations for oral ingestion for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; pharmaceutical and veterinary preparations for topical administration for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; medicaments for inhalation therapy; pharmaceutical preparations, namely, pulmonary delivery compositions for use in facilitating the inhalation of pharmaceuticals, namely, drug delivery agents consisting of compounds that facilitate delivery by inhalation of a wide range of pharmaceuticals; medicaments for the treatment of erectile dysfunction; medicaments for the treatment of chronic obstructive pulmonary disease; medicaments for the treatment of premature ejaculation; medicaments for the treatment of cystic fibrosis; medicaments for the treatment of female sexual dysfunction; medicaments for the treatment of migraines; medicaments for the treatment of asthma; all of the above goods not for use in the dental field
• GS0101: Surgical, medical, and veterinary apparatus, instruments and parts and fittings therefor, namely, drug delivery devices and parts and fittings therefor, namely, drug delivery systems being nebulizers for medical purposes; inhalers sold empty for medical or therapeutic purposes and parts and fittings therefor; active dry powder inhalers sold empty for medical or therapeutic purposes and parts and fittings therefor; passive dry powder inhalers sold empty for medical or therapeutic purposes and parts and fittings therefor; nebulisers for inhalation therapy, namely, respiration therapy, and parts and fittings therefor; inhaler devices sold empty for medical or therapeutic purposes and parts and fittings therefor; all of the above goods not for use in the dental field
• GS0421: Scientific research and technological services, namely, research, design, analysis, and testing, in the field of pharmaceuticals and drug delivery systems, and drug delivery systems and devices; Scientific research and technological services, namely, research in the field of medicine; industrial analysis and research services in the fields of drug delivery systems and devices; research services in the fields of medicine; pharmaceutical research services; pharmaceutical products development services; device and product safety testing services;

Case File Event Statements

• 10/13/2023 - a year ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 10/16/2023 - a year ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 5/29/2024 - 5 months ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 6/10/2024 - 5 months ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 6/10/2024 - 5 months ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 9/6/2024 - 2 months ago

  8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 9/6/2024 - 2 months ago

  9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 9/6/2024 - 2 months ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 9/12/2024 - 2 months ago

  11 - ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Type: ERRR

• 9/9/2024 - 2 months ago

  10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 6/10/2024 - 5 months ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN